InChI=1S/C20H28O4/c1- 2- 3- 6- 10- 17(21) 13- 14- 18- 16(12- 15- 19(18) 22) 9- 7- 4- 5- 8- 11- 20(23) 24/h3- 4,6- 7,12,14- 17,21H,2,5,8- 11,13H2,1H3,(H,23,24) /b6- 3- ,7- 4- ,18- 14+/t16- ,17- /m0/s1 |
MSLYURLMFHGOET-OLBAJUCDSA-N |
C(CCC(O)=O)/C=C\C[C@@H]1/C(/C(C=C1)=O)=C\C[C@H](C/C=C\CC)O |
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(5Z)- 7- {(1S,5E)- 5- [(3S,5Z)- 3- hydroxyoct- 5- en- 1- ylidene]- 4- oxocyclopent- 2- en- 1- yl}hept- 5- enoic acid
|
(5Z,9Z,12E,15S,17Z)-15-hydroxy-11-oxoprostatetraenoic acid
|
ChEBI
|
δ(12)-PGJ3
|
ChEBI
|
Δ(12)-prostaglandin J3
|
ChEBI
|
δ(12)-prostaglandin J3
|
ChEBI
|
delta-12-PGJ3
|
SUBMITTER
|
29567731
|
Reaxys Registry Number
|
Reaxys
|
21967980
|
PubMed citation
|
Europe PMC
|
22194393
|
PubMed citation
|
Europe PMC
|
22442337
|
PubMed citation
|
Europe PMC
|
24312486
|
PubMed citation
|
Europe PMC
|
25098181
|
PubMed citation
|
Europe PMC
|
26290393
|
PubMed citation
|
Europe PMC
|
26339618
|
PubMed citation
|
Europe PMC
|
27187634
|
PubMed citation
|
Europe PMC
|
|